Celularity Inc. Effective Tax Rate
Celularity Inc. (CELU) reported Effective Tax Rate of 0.00% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-07-30.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2024-07-30
- Celularity Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.00%.
- Celularity Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
- Celularity Inc. effective income tax rate reconciliation, percent for fiscal 2021 was 0.00%, a 100.00% decline from fiscal 2020.
- Celularity Inc. effective income tax rate reconciliation, percent for fiscal 2020 was 2.20%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | 0.00% 10-K · filed 2024-07-30 | ||
| 2022-12-31 | 0.00% 10-K · filed 2024-07-30 | ||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-31 | ||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-12 | ||
| 2020-12-31 | 2.20% 10-K · filed 2022-03-31 | -7.90% 10-K · filed 2021-03-04 | |
| 2020-09-30 | 2.10% 10-Q · filed 2021-11-12 | ||
| 2019-12-31 | -51.20% 10-K/A · filed 2021-05-24 | 21.00% 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |